Agios Pharmaceuticals (AGIO) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -407.3 | -309.5 | -296.1 | -389.8 | -373.0 | -380.4 | ||
| Changes by years, y/y, % | +40% | -24% | -4% | +32% | -4% | +5.1% | |||
Agios Pharmaceuticals. OCF, bln rub
Agios Pharmaceuticals. OCF, changes, %
Agios Pharmaceuticals. OCF, sum by quarters, bln rub
Agios Pharmaceuticals (AGIO) OCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OCF, bln rub | ? | -111.5 | -77.1 | -88.2 | -96.2 | -118.9 | -380.4 | |
| Changes by years, y/y, % | +12% | +6% | +5% | -28% | +7% | |||
| Changes by quarters, q/q, % | -16% | -31% | +14% | +9% | +24% | |||